| Mahrenholz, Carsten C. (Coldplasmatech 202012 Managing Director + Co-Founder) |
Managing Director |
Coldplasmatech GmbH |
Germany |
| Maier, Elmar (EM Biotech 2009– CEO + Founder before iOmx Therapeutics + GPC Biotech) |
Chief Executive Officer (CEO) |
|
Germany |
| Maier, Hans (Bayer 200801 Head Global Business Unit Diagnostic Imaging Bayer Schering Pharma) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Maier, Robert (ladenzeile.de Founder) |
n. a. |
|
|
| Maier, Thomas (Wacker Biotech 200511) |
Managing Director |
Wacker (Group) |
Germany |
| Main, Alan (Sanofi 201610– EVP Consumer Healthcare before Bayer President HealthCare Medical Care business) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Mainolfi, Nello (Kymera Therapeutics 201911– CEO before CSO + Co-Founder before Raze Therapeutics) |
Chief Executive Officer (CEO) |
Kymera Therapeutics Inc. (Nasdaq: KYMR) |
United States (USA) |
| Maiore, Alain (Mnemo Therapeutics 202106 CEO + Founder formerly Evotec BioSystems + Cerep) |
Chief Executive Officer (CEO) |
Evotec (Group) |
Germany |
| Mairhofer, Jürgen (enGenes Biotech GmbH 201509 Managing Director) |
Chief Executive Officer (CEO) |
EnGenes Biotech GmbH |
Austria |
| Makarov, Alexander A. (Thermo Fisher 200607– Director Global Research LS Mass Spec before Masslab Ltd + HD Technologies) |
Research & Development Manager |
Thermo Fisher (Group) |
Germany |
| Makhijani, Vinod (Roche 201506 VP + Project Leader at Roche Sequencing Business Development) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Switzerland |
| Malcolm, Alastair (Applied Microarrays 200705 founder before GE Healthcare before Amersham before Motorola) |
Company Founder |
Schott (Group) |
United States (USA) |
| Maleck, Klaus (B Braun 201302– CEO TETEC AG before Evotec 201008– Corp Developm before Exec VP Financing + BioGeneriX) |
Chief Financial Officer (CFO) |
B. Braun (Group) |
Germany |
| Malfent, Lucia (MC Services 201211 before Intercell VP Global Head Corporate Communications) |
public relations / investor relations |
MC Services AG |
Germany |
| Malgouyres, Pascale (Poxel 200904– Business Development Director) |
Business Development Manager / Strategy Manager |
Poxel (Group) |
France |
| Malier, Vanessa (Kurma 201412 Partner) |
Partner (venture partner) |
Eurazeo (Group) |
France |
| Malievsky, Allan (Atai Life Sciences 202206 Senior Director External Affairs) |
Public Relations Manager / Investor Relations Manager |
Atai Life Sciences (Group) |
Netherlands |
| Malik, Arif (Microdiscovery 200501 Managing Director + Co-Founder) |
Managing Director |
MicroDiscovery GmbH |
Germany |
| Malik, Kemal (Bayer 201402– Executive Board Member for Innovation joined Bayer 1995 before BMS UK) |
Board member, executive |
Bayer (Group) |
Germany |
| Malik, Rajesh (Raj) (G1 Therapeutics 201406– CMO before Agennix + Adherex Technologies + EMD Pharmaceuticals+ BMS) |
Chief Medical Officer (CMO) |
HOPP Group (family of Dietmar Hopp) |
Germany |
| Malik, Shahzad (Advent Venture Partners 201402 General Partner) |
General Partner (venture partner) |
Advent Venture Partners (Advent Ltd.) |
United Kingdom (GB) |
| Malin, Reinhard (Boehringer Ingelheim 201505 Director Media + PR) |
Public Relations Manager / Investor Relations Manager |
Boehringer Ingelheim (Group) |
Germany |
| Malkomes, Axel-Sven (Medigene 201904 – CFO + Chief BusDev Officer before Barclays + Société Générale + 3i + Merck KGaA) |
Chief Financial Officer (CFO) |
Medigene (Group) |
Germany |
| Mallik, Ameet (ADC Therapeutics 202205– CEO before Rafael Holdings + 16y at Novartis + McKinsey & Co) |
Chief Executive Officer (CEO) |
ADC Therapeutics (Group) |
Switzerland |
| Malm, Anders (Manipal 201403– Managing Director of Ecron Acunova GmbH before Ecron Acunova A/S) |
Managing Director |
Manipal (Group) |
Germany |
| Malmström, Johan (Biognosys 200809– CSO + co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Biognosys AG |
Switzerland |
| Man, Anthony (Basilea Pharmaceutica –201212 CEO RESIGNED 12/12) |
Chief Executive Officer (CEO) |
Basilea (Group) |
Switzerland |
| Manchester, Keith (QVT 201705 Managing Director + Head Life Sciences QVT Financial LP) |
Investment Manager |
QVT (Group) |
United States (USA) |
| Mandel, Tristan (Mack Brooks Exhibitions 201907 PR + Marketing Officer) |
Public Relations Manager / Investor Relations Manager |
Mack Brooks Exhibitions Ltd. |
United Kingdom (GB) |
| Mandelkern, Dave (Maverix Biomics 201306 CEO) |
Chief Executive Officer (CEO) |
Maverix Biomics Inc. |
United States (USA) |
| Mander, Thomas (Tom) (Domainex 202004– CEO joined 201504 as COO before Charles River + Asterand + Tripos UK + Evotec) |
Chief Executive Officer (CEO) |
Domainex Ltd. |
United Kingdom (GB) |
| Mang, Manuel (M2. Technology & Project Consulting 201201 Managing Director) |
Managing Director |
M2. Technology & Project Consulting UG (haftungsbeschränkt) |
Germany |
| Mangasarian, Aram (Noxxon 201005 CBO before Novexel since 200511 VP BusDev before ExonHit VP BusDev) |
Chief Business Officer (CBO) |
Noxxon Pharma AG |
Germany |
| Mangelschots, Iris (Bruker Corp 201612 President of Bruker BioSpin Appplied, Industrial + Clinical division) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
| Mangeolle, Jean-Paul (Danaher –201709 President of Sciex before Millipore RETIRED 9/17) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Mangold, Sebastian (mk2 Biotechnologies 202107 Managing Director + Co-Founder) |
Managing Director |
mk2 Biotechnologies GmbH |
Germany |
| Manieri, John (Cosmo 201707– Head of IR + Head of Investment Committee before Bellevue Asset Management) |
Public Relations Manager / Investor Relations Manager |
Cosmo Pharmaceuticals (Group) |
Ireland, Republic of |
| Mann, Cornelia (European Circular Bioeconomy Fund 202109 Marketing + Communications Manager) |
Public Relations Manager / Investor Relations Manager |
ECBF (European Circular Bioeconomy Fund) (Group) |
Luxembourg |
| Mann, Erica L. (Bayer 201103– Head Bayer HealthCare Consumer Care Div before General Manager Pfizer Nutritional Health) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
|
| Mann, Jessica (Roche 201008 Head Translational Medicine before Evolva before Speedel before Roche before Novartis) |
Chief Medical Officer (CMO) |
Roche (Group) |
Switzerland |
| Mann, Matthias (Max Planck 200808 MPI for Biochemistry) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Mann, William (Helsinn 201705 CEO of Helsinn Therapeutics (U.S.) Inc) |
Chief Executive Officer (CEO) |
Helsinn (Group) |
United States (USA) |
| Mann, Wolfgang (Olympus before Advalytix AG before Alopex GmbH Managing Director) |
Managing Director |
BlueCatBio (BCB) (Group) |
Germany |
| Mannhardt, Boris (Biocom Projektmanagement GmbH 200710 Managing Director + Apanovis before IBG Sachsen-Anhalt + Bio-M) |
Managing Director |
Biocom (Group) |
Germany |
| Mannheims, Willi (eCapital 202110 Managing Partner) |
Managing Partner (investment firm) |
eCapital (Group) |
Germany |
| Manninga, Heiko (Neuway Pharma GmbH 201504 Managing Director) |
Managing Director |
Neuway Pharma GmbH |
Germany |
| Mannix, Kevin (BeiGene 202205 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
BeiGene (Group) |
China |
| Manore, Hadar (Paragon Conventions 201304 Project Manager – Industry Liaison) |
Event Manager / Conference Manager |
Paragon (IL) (Group) |
Switzerland |
| Mansukhani, Robin (Deciduous Therapeutics 202209 CEO) |
Chief Executive Officer (CEO) |
Deciduous Therapeutics |
|
| Manth, Stefan M. (Mologen 201904– CEO prior Supervisory Board + SAB Member before Roche for 20 years |
Chief Executive Officer (CEO) |
Mologen (Group) |
Germany |
| Manthey, Jessica (Flanders (govt) 201704 Investment Promotion Manager at FIT in Berlin) |
Governmental Officer (personnel) |
Flanders (govt) |
Belgium |
| Manting, Erik (Immunicum AB 202110 before CEO of DCPrime) |
Chief Executive Officer (CEO) |
Immunicum (Group) |
Sweden |
| Manto, Michele (Galapagos 202001– promoted to CCO joined 201709 as SVP Commercial Operations before AbbVie |
Chief Commercial Officer (CCO) |
Galapagos (Group) |
Belgium |
| Manzello, John (Promosome 200810 CEO) |
Chief Executive Officer (CEO) |
Promosome LLC |
United States (USA) |
| Maraganore, John (ARCH Venture 202112– Venture Partner before founding CEO of Alnylam + Millennium + Biogen) |
Venture Partner |
ARCH Venture (Group) |
United States (USA) |
| Maraschiello, Ciriaco (Evotec 202107 EVP Global Head of Drug Development + Head of Verona Site) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Italy |
| Marathe, Nisha (Roche 202105 Investment Director at Roche Venture Fund) |
Investment Manager |
Roche (Group) |
Switzerland |
| Marc-Kreucher, Frederic (Merck (DE) 201411 Technology Scouting Manager at Millipore SAS) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
United States (USA) |
| Marcell, Shawn M. (Metamark Genetics 201304– CEO before Hologic + Sequencom + SensíGen) |
Chief Executive Officer (CEO) |
Metamark Genetics Inc. |
United States (USA) |
| Marchfelder, Anita (Univ Ulm 201503 Professor) |
Professor |
University of Ulm |
Germany |
| Marchington, Tony (Avacta 201103 CEO of Oxford Medical Diagnostics) |
Chief Executive Officer (CEO) |
Avacta (Group) |
United Kingdom (GB) |
| Marcinowski, Stefan (BASF 201002 + 2008– VP Max Planck Society + 201002– Member BioÖkonomieRat) |
n. a. |
BASF (Group) |
Germany |
| Marcus, Katrin (Univ Bochum 201911 Prof + Director of Medical Proteome Center Bochum) |
Professor |
University of Bochum (Ruhr-Universität Bochum, RUB) |
Germany |
| Mardin, Balca (BioMed X 201611– Group Leader before EMBL) |
Researcher (industry) |
BioMed X GmbH |
Germany |
| Marengere, Luc (TVM 201308 Managing Partner) |
Managing Partner |
TVM (Group) |
Germany |
| Marett, Sean (BioNTech 202012 CBO + CCO 201506 COO before Evotec) |
Chief Operating Officer (COO) |
BioNTech (Group) |
Germany |
| Margeson, Kristen (Atlas Venture 201601 Director IR + Marketing) |
Public Relations Manager / Investor Relations Manager |
Atlas Venture (Group) |
United States (USA) |
| Margraf, Iris (Coral BioNet 201102 Director Business Development at Scil Technology GmbH) |
Business Development Manager / Strategy Manager |
Coral BioNet (Group) |
Germany |
| Marguerre, Wolfgang (Octapharma 201209 Chairman + Founder) |
Board member |
Octapharma (Group) |
Switzerland |
| Mariën, Rudi (Innogenetics 2007 Chairman + major owner) |
Venture Partner |
Biovest N.V. (Belgium, Rudi Mariën) |
Belgium |
| Mariggi, Giovanni (Medicxi 202208 Partner) |
Partner (venture partner) |
Medicxi Ventures (formerly Index Ventures Life Sciences) |
United Kingdom (GB) |
| Marini, Davide (Firefly BioWorks 201310 CEO) |
Chief Executive Officer (CEO) |
Firefly BioWorks Inc. |
United States (USA) |
| Marini, Luca (Xyence Capital 202205 CEO) |
Chief Executive Officer (CEO) |
Xyence Capital SGR |
Italy |
| Marino, Daniela (Cutiss 202006 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cutiss AG |
Switzerland |
| Marinucci, Francesco (Partec 201212 Director of Partec Essential Healthcare division) |
President/Director/Head Business Group/Unit/Division |
Sysmex (Group) |
Germany |
| Mark, Antje (JeNaCell GmbH 201507 Marketing Manager) |
Sales Manager / Marketing Manager |
JeNaCell GmbH |
Germany |
| Mark, Daniel L. (SpinDiag GmbH 201707 Managing Director) |
Managing Director |
Spindiag GmbH |
Germany |
| Markfort, Rainer (Dentons 201501– Partner before Mayer Brown Düsseldorf + White & Case Berlin) |
Attorney / Lawyer |
Dentons (Group) |
Switzerland |
| Markó, Kornél G. (Averbis GmbH 2007– Managing Director + Co-Founder) |
Managing Director |
Acus Laboratories GmbH |
Germany |
| Markovic, Sandra (LeadXPro 201804 Discovery Project Leader) |
Research & Development Manager |
LeadXPro AG |
Switzerland |
| Marks, Daniel (RA Capital 202204 Principal) |
Principal (venture capital) |
RA Capital Management L.P. |
United States (USA) |
| Marks, Eric (BRAIN 201511–201610 COO before AB Enzymes 2006–2015 RESIGNED 10/16) |
Chief Operating Officer (COO) |
BRAIN Biotech (Group) |
Germany |
| Marks, Ian (Salesforce 202108 VP Life Sciences before GSK + Novartis) |
President/Director/Head Business Group/Unit/Division |
Salesforce.com Inc. (NYSE: CRM) |
United States (USA) |
| Marlière, Philippe (Global Bioenergies 201702 Partner + Co-Founder) |
Company Founder |
Global Bioenergies (Group) |
France |
| Marotta, Marco (Relief Therapeutics 202111– promoted to CBO joined with acquisition of APR Applied Pharma Research) |
Business Development Manager / Strategy Manager |
Relief Therapeutics (Group) |
Switzerland |
| Marriott, Peter (SGS 201012 Global Technical & Accreditation Manager) |
Technical Manager |
SGS (Group) |
Switzerland |
| Marron, Damian (Agalimmune 201603 CEO before TxCell + Cytheris + Trophos + NiCox + 3M + Orphan Europe) |
Chief Executive Officer (CEO) |
BioLineRx (Group) |
United Kingdom (GB) |
| Marsat, Jean-Luc (EverImmune 202111 CEO formerly SGS 201611 Managing Director at SGS Clinical Research) |
Chief Executive Officer (CEO) |
EverImmune (FR) |
France |
| Marschner, Jens-Peter (Zelluna 201906– CMO before AbbVie + Affimed + Merck KGaA + Bayer + Boehringer Mannheim) |
Chief Medical Officer (CMO) |
Affimed (Group) |
Germany |
| Marseille, Oliver (Hemovent GmbH 201602 Managing Director (CTO) + Co-Founder) |
Managing Director |
Hemovent GmbH |
Germany |
| Marshak, Daniel R. (PerkinElmer 200807 CSO President China) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
PerkinElmer (Group) |
United States (USA) |
| Marshak, Daniel R. (Tecan 201710– Board proposed before PerkinElmer + Cambrex) |
Board member, non-executive |
Tecan (Group) |
Switzerland |
| Marshall, Alan G. (Florida State Univ 201003 Professor + National High Magnetic Field Labaoratory Director ICR Program) |
Professor |
Florida State University (FSU) |
United States (USA) |
| Marshall, Fiona H. (Novartis 202211– President of NIBR before Merck + Heptares + Millennium Pharma + GSK) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| Martello, Wan Ling (Nestlé 201402 CFO) |
Chief Financial Officer (CFO) |
Nestlé (Group) |
Switzerland |
| Martens, Hubert (Salvia BioElectronics 202009 CEO + Founder) |
Chief Executive Officer (CEO) |
Salvia BioElectronics B.V. |
Netherlands |
| Martens, Lejon (A & M Labor für Analytik 201009 Head Mass Spec Lab) |
Head Mass Spectrometry / NMR Laboratory (industry) |
A&M Labor für Analytik (Group) |
Germany |
| Martens, Tom (UgenTec NV 201712 Managing Director) |
Managing Director |
UgenTec N.V. |
Belgium |
| Martin, Alex (Affectis 201003–CEO before CFO before Intercept before BioXell 200606 CFO before Novartis) |
Chief Executive Officer (CEO) |
Affectis Pharmaceuticals AG |
Germany |
| Martin, Chris (Auven Therapeutics 201506 CEO of ADC Therapeutics before CEO of Spirogen Ltd) |
Managing Director |
ADC Therapeutics (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 44 45 46 ... 81 82 83 
![Picture [iito] No Content Marketing 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
